Gilead, Agenus sign deal to develop immuno-oncology therapies
December 20, 2018 at 07:48 AM EST
Gilead Sciences Inc has inked a collaboration agreement with Agenus Inc for the development and marketing of up to five novel immuno-oncology therapies.